Amankulor Nduka M, Xu Ran, Iorgulescu J Bryan, Chapman Talia, Reiner Anne S, Riedel Elyn, Lis Eric, Yamada Yoshiya, Bilsky Mark, Laufer Ilya
Department of Neurological Surgery, University of Pittsburgh School of Medicine, 200 Lothrop St, Pittsburgh, PA 15213, USA.
Department of Neurological Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA; Department of Medical Biophysics, Institute of Physiology and Pathophysiology, Heidelberg University, Grabengasse 1, 69117 Heidelberg, Germany.
Spine J. 2014 Sep 1;14(9):1850-9. doi: 10.1016/j.spinee.2013.10.028. Epub 2013 Nov 8.
Spine metastases occur frequently in patients with cancer. A variety of surgical approaches, including anterior transcavitary, lateral extracavitary, posterolateral, and/or combined techniques are used for spinal cord decompression and restoration of spinal stability. The incidence of symptomatic hardware failure is unknown for the majority of these approaches.
The purpose of this study was to determine the incidence of symptomatic hardware failure and the associated risk factors in patients with metastatic epidural spinal cord compression (MESCC).
STUDY DESIGN/SETTING: This was a retrospective study.
The current series analyzes a cohort of 318 patients who underwent separation surgery, which involves single-stage posterolateral decompression and posterior segmental instrumentation for MESCC.
The event of interest was hardware failure; the competing event was death resulting from any cause. All patients were monitored for survival analysis. A competing risk analysis was conducted to examine univariately a number of potential risk factors associated with hardware failure, including junctional level, gender, construct length, and the presence or absence of prior chest wall resection.
A retrospective analysis and chart review were performed for 318 consecutive patients who underwent posterolateral decompression and posterior screw-rod fixation without supplemental anterior fixation from March 2004 to June 2011 at our institution. The median follow-up time for survivors without hardware failure was 399 days (range, 9-2,828), with a mean operative time of 3 hours. A total of 78% of patients died during the 7-year study period.
Of the 318 patients, nine (2.8%) exhibited signs and symptoms of hardware failure and required revision of the instrumentation. Patients with chest wall resection and those with initial construct length greater than six contiguous spinal levels exhibited a statistically significantly higher risk of symptomatic hardware failure than their counterparts. We observed a trend toward an increased risk of failure in women compared with men (p=.09).
The incidence of hardware failure is low in patients with MESCC who undergo posterolateral decompression and posterior screw-rod instrumentation. Moreover, the short operative time and low morbidity profile associated with this approach make it a reliable and acceptable method for the surgical treatment of MESCC. Patients with constructs spanning six or more levels or those with prior chest wall resection are at higher risk for instrumentation failure.
脊柱转移瘤在癌症患者中很常见。多种手术方法,包括前路经胸腔、外侧经胸腔外、后外侧和/或联合技术,用于脊髓减压和恢复脊柱稳定性。这些方法中大多数出现症状性内固定失败的发生率尚不清楚。
本研究的目的是确定转移性硬膜外脊髓压迫症(MESCC)患者症状性内固定失败的发生率及相关危险因素。
研究设计/地点:这是一项回顾性研究。
本系列分析了318例行分期手术的患者队列,该手术包括针对MESCC的单阶段后外侧减压和后路节段性内固定。
关注的事件是内固定失败;竞争事件是任何原因导致的死亡。对所有患者进行生存分析监测。进行竞争风险分析以单因素检查与内固定失败相关的一些潜在危险因素,包括交界水平、性别、内固定长度以及是否曾行胸壁切除术。
对2004年3月至2011年6月在我院连续接受后外侧减压和后路螺钉-棒固定且未行前路补充固定的318例患者进行回顾性分析和病历审查。无内固定失败的幸存者的中位随访时间为399天(范围9 - 2828天),平均手术时间为3小时。在7年研究期间,共有78%的患者死亡。
318例患者中,9例(2.8%)出现内固定失败的体征和症状,需要对内固定进行翻修。行胸壁切除术的患者和初始内固定长度大于连续6个脊柱节段的患者出现症状性内固定失败的风险在统计学上显著高于未行胸壁切除术的患者和初始内固定长度小于6个脊柱节段的患者。我们观察到女性内固定失败风险有高于男性的趋势(p = 0.09)。
接受后外侧减压和后路螺钉-棒内固定的MESCC患者内固定失败的发生率较低。此外,该方法手术时间短且发病率低,使其成为治疗MESCC的可靠且可接受的手术方法。内固定跨越6个或更多节段的患者或曾行胸壁切除术的患者内固定失败风险较高。